Homeopathic medicines in heavy menstrual bleeding due to tumors of uterus

Efficacy of individualized homeopathic medicines in heavy menstrual bleeding due to uterine fibroids in reproductive age group: Double-blind, randomized, placebo-controlled clinical trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/021998

Enrollment

Registered

2019-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D259- Leiomyoma of uterus, unspecified

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies, as decided appropriate to the case or condition: Intervention is planned as administering individualized homeopathic medici

dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. The patients will be advised to ta

dosage and repetition depending upon the individual requirement of the cases. The patients will be advised to take iron rich diet. Duration of therapy: 3 months

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from heavy menstrual bleeding due to uterine fibroid (PBAC score 100 points or above indicate heavy menstrual bleeding) 2. Age: 18-45 years 3. Uterine fibroid detected on Trans-abdominal Sonography 4. Patients taking Oral Contraceptive Pills will be considered for the study after giving a wash-out period of 1 month 5. Patients giving written consent to participate in the study. 6. Literate patients, who can read and write in Bengali

Exclusion criteria

Exclusion criteria: 1. Patients who are too sick for consultation. 2. Unwilling to take part and not giving consent to join the study. 3. Unable to read patient information sheet. 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life- threatening illness affecting quality of life or any organ failure. 5. Patients suffering from uro-genital polyp, uterine fibroid causing hydronephrosis, fibroid with solid ovarian mass, calcified fibroid. 6. Blood hemoglobin level less than 7gm/dl 7. Patients desiring immediate surgical management for uterine fibroid. 8. Pregnancy and lactation. 9. Substance abuse and/or dependence. 10. Self-reported immune-compromised state. 11. Undergoing homeopathic treatment for any chronic disease within last 6 months

Design outcomes

Primary

Measure	Time frame
Highams Pictorial Blood Loss Assessment Chart (PBAC) scoringTimepoint: Baseline, every month, up to 3 months	—

Secondary

Measure	Time frame
b. Uterine Fibroid Symptom And Health - Related Quality of Life (UFS-QOL) questionnaireTimepoint: Baseline and 3 months;Size and number of the fibroidsTimepoint: Baseline and 3 months	—

Countries

India

Contacts

Public ContactOmpriya Mishra

National Institute of Homoeopathy

drompriyanih@gmail.com8240359414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026